PCM
IMA

Prelude Capital Management’s ImageneBio Inc IMA Stock Holding History

Prelude Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65K Sell
12,990
-505
-4% -$3.28K 0.01% 1104
2025
Q4 		$93.1K Buy
+13,495
New +$100K 0.01% 1197
2024
Q4 		– Sell
-4,220
Closed -$87.6K – 1360
2024
Q3 		$87.6K Buy
+4,220
New +$85.3K 0.01% 1165

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prelude Capital Management's IMA Position: Q1 2026 in Review

Prelude Capital Management reduced its ImageneBio Inc (IMA) stake by 3.7% in Q1 2026, selling an estimated $3.28K and leaving 12,990 shares worth $65K. The position accounts for 0.01% of the portfolio, ranked #1104.

Prelude Capital Management first reported a position in IMA in Q3 2024 and has held it in 3 quarters since. The position peaked at $93.1K in Q4 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Prelude Capital Management held 12,990 shares of ImageneBio Inc worth $65K as of Q1 2026.
  • Prelude Capital Management sold 505 ImageneBio Inc shares in Q1 2026, an estimated $3.28K.
  • ImageneBio Inc made up 0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1104 holding.
  • Prelude Capital Management first reported a position in ImageneBio Inc in Q3 2024 and has held it in 3 quarters since.
  • Prelude Capital Management's ImageneBio Inc position peaked at $93.1K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.